September 23, 2016

Compumedics Limited (ASX: CMP) (“Compumedics” and “Company”) – an international leader in medical devices for sleep, brain and ultrasonic blood-flow monitoring – is pleased to announce that it has successfully completed a $6.5m placement, which was announced to market on 21 September 2016.

The placement comprised the issue of $4.5m of new shares in the Company and a $2.0m sell down of existing shares in Compumedics.

The placement was undertaken at $0.54 per share (3.0% discount to the VWAP immediately prior to the trading halt) and within the Company’s 15% placement capacity in accordance with ASX Listing Rule 7.1.

Dr David Burton, Executive Chairman of Compumedics, said:

“We are very pleased with the level and quality of support shown for the Company by this capital raising, which closed significantly oversubscribed.

“We are also very grateful to our long-term supporting shareholders and are delighted to welcome our new institutional shareholders onto our share register.

“This placement strengthens our balance sheet, providing greater flexibility to pursue the commercialisation of the current opportunities identified by Compumedics, whilst the sell-down improves the liquidity of the Company’s tradable securities.”

PAC Partners served as sole lead managers for the capital raising.

The new shares are scheduled to be issued on Monday, 26 September, 2016.

About Compumedics Limited

Compumedics Limited [ASX: CMP] is a medical device company involved in the development, manufacture and commercialisation of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. The company owns US based Neuroscan and Germany based DWL Elektronishe GmbH. In conjunction with these two subsidiaries, Compumedics has a broad international reach, including the Americas, Australia and Asia Pacific, Europe and the Middle East.

Executive Chairman Dr David Burton founded Compumedics in 1987. In the same year the company successfully designed and installed the first Australian, fully computerised sleep clinic at Epworth Hospital in Melbourne. Following this early success, Compumedics focused on the development of products that sold into the growing international sleep clinic and home monitoring markets.

Compumedics listed on the Australian Securities Exchange in 2000. Over the years, Compumedics has received numerous awards, including Australia’s Exporter of the Year, and has been recognised as a Top 100 Innovator by both German and Australian governments.

For further information please contact:

Dr David Burton
Executive Chairman, CEO Executive Director
Phone: + 61 3 8420 7300
Fax: +61 3 8420 7399

David Lawson
Chief Financial Officer
Phone: + 61 3 8420 7300
Fax: +61 3 8420 7399

Investor Relations, Media & PR enquires:

Rod North
Managing Director
Bourse Communications Pty Ltd
Phone: +61 3 9510 8309
Mobile: 0408 670 706

Richard Allen
Oxygen Financial PR
Ph: + 61 3 9915 6341
Mob: 0403 493 049